The future of the healthcare and life sciences industry

What’s on the horizon for healthcare innovators? We surveyed over 2000 global senior decision makers to find out.

Since the pandemic there has been a new appreciation for contributions made in the battle to save lives. As public confidence builds, many in the healthcare and life sciences sector are encouraged to apply learnings from the past two years to achieve future success.

To provide an extensive view of the industry’s emerging trends, we surveyed 2000 senior decision makers across the globe, with a particular focus on the legal challenges that lie ahead.

Our report shows that:

  • digitalisation is gathering pace, from accelerating the M&A negotiation process, to the rise of remote consultations;
  • the war for talent continues as the sector aims to attract digital talent and emerging employment law shifts to address hybrid and remote working arrangements;
  • ESG is becoming a key focus, as the industry aims to keep pace with other sectors; and
  • that supply chains, product liability, disputes, cyber security and the rise of regulation are some of the biggest areas of challenge.

As you focus on the future, so do we. Explore our report to find out what’s next for healthcare innovators.

Hear from Alexandre Regniault, Head of Healthcare and Life Sciences at Simmons & Simmons

Alexandre tells us more about the research we've conducted.

Video Thumbnail
2:36

Have any questions?

Drop us an email to discuss how we can help you navigate any current challenges your business may be facing.

This document (and any information accessed through links in this document) is provided for information purposes only and does not constitute legal advice. Professional legal advice should be obtained before taking or refraining from any action as a result of the contents of this document.